HomeCompareVINCU vs EQR

VINCU vs EQR: Dividend Comparison 2026

VINCU yields 7.41% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQR wins by $15.1K in total portfolio value· pulled ahead in Year 3
10 years
VINCU
VINCU
● Live price
7.41%
Share price
$27.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.7K
Annual income
$1,184.90
Full VINCU calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — VINCU vs EQR

📍 EQR pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVINCUEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VINCU + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VINCU pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VINCU
Annual income on $10K today (after 15% tax)
$629.63/yr
After 10yr DRIP, annual income (after tax)
$1,007.17/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, EQR beats the other by $3,647.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VINCU + EQR for your $10,000?

VINCU: 50%EQR: 50%
100% EQR50/50100% VINCU
Portfolio after 10yr
$40.2K
Annual income
$3,330.25/yr
Blended yield
8.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

VINCU
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VINCU buys
0
EQR buys
0
No recent congressional trades found for VINCU or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVINCUEQR
Forward yield7.41%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$32.7K$47.8K
Annual income after 10y$1,184.90$5,475.61
Total dividends collected$9.7K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: VINCU vs EQR ($10,000, DRIP)

YearVINCU PortfolioVINCU Income/yrEQR PortfolioEQR Income/yrGap
1$11,441$740.74$11,380$679.82+$61.00VINCU
2$13,034$792.02$13,014$837.25+$20.00VINCU
3← crossover$14,789$843.26$14,961$1,036.20$172.00EQR
4$16,719$894.25$17,297$1,289.22$578.00EQR
5$18,834$944.79$20,121$1,613.15$1.3KEQR
6$21,147$994.69$23,561$2,030.84$2.4KEQR
7$23,671$1,043.78$27,783$2,573.54$4.1KEQR
8$26,420$1,091.93$33,013$3,284.39$6.6KEQR
9$29,408$1,139.01$39,547$4,223.51$10.1KEQR
10$32,652$1,184.90$47,791$5,475.61$15.1KEQR

VINCU vs EQR: Complete Analysis 2026

VINCUStock

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

Full VINCU Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this VINCU vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VINCU vs SCHDVINCU vs JEPIVINCU vs OVINCU vs KOVINCU vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.